Exclusive enteral nutrition ameliorates mesenteric adipose tissue alterations in patients with active Crohn's disease

Clinical Nutrition

Volumn 33, Issue 5, 2014, Pages 850-858

  Feng, Yun ^a   Li, Yi ^a   Mei, Shuqin ^a   Zhang, Liang ^a   Gong, Jianfeng ^a   Gu, Lili ^a   Zhang, Wei ^a   Zhu, Weiming ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Adipokines; Crohn's disease; Enteral nutrition; Mesenteric adipose tissue

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BLOOD; BODY MASS; CROHN DISEASE; DOWN REGULATION; ENTERIC FEEDING; FEMALE; GENETICS; HUMAN; LABORATORY DIAGNOSIS; MALE; METABOLISM; PATHOPHYSIOLOGY; UPREGULATION; YOUNG ADULT;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CROHN DISEASE; DOWN-REGULATION; ENTERAL NUTRITION; FEMALE; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; RNA, MESSENGER; SPECIMEN HANDLING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 84906062302     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.10.009     Document Type: Article

References (30)

1. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008, 8:458-466.
2. Crohn B.B., Ginzburg L., Oppenheimer G.D. Regional ileitis - a pathologic and clinical entity (reprinted). J Am Med Assoc 1984, 251:73-79.
3. Sheehan A.L., Warren B.F., Gear M.W.L., Shepherd N.A. Fat-wrapping in Crohns-disease - pathological basis and relevance to surgical practice. Br J Surg 1992, 79:955-958.
4. Borley N.R., Mortensen N.J., Jewell D.P., Warren B.F. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol 2000, 190:196-202.
5. Drouet M., Dubuquoy L., Desreumaux P., Bertin B. Visceral fat and gut inflammation. Nutrition 2012, 28:113-117.
6. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314:1-16.
7. Rampton D.S. Regular review - management of Crohn's disease. BMJ 1999, 319:1480-1485.
8. Voitk A.J., Echave V., Feller J.H., Brown R.A., Gurd F.N. Experience with elemental diet in treatment of inflammatory bowel disease - is this primary therapy. Arch Surg 1973, 107:329-333.
9. Rubio A., Pigneur B., Garnier-Lengline H., Talbotec C., Schmitz J., Canioni D., et al. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmcol Therap 2011, 33:1332-1339.
10. Hiwatashi N. Enteral nutrition for Crohn's disease in Japan. Dis Colon Rectum 1997, 40:S48-S53.
11. Yamamoto T., Nakahigashi M., Umegae S., Kitagawa T., Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 2005, 11:580-588.
12. Yamamoto K., Kiyohara T., Murayama Y., Kihara S., Okamoto Y., Funahashi T., et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005, 54:789-796.
13. Mencarelli A., Distrutti E., Renga B., D'Amore C., Cipriani S., Palladino G., et al. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS One 2011, 6:e22978. 10.1371/journal.pone.0022978.
14. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 2007, 56:577-583.
15. El-Matary W. Enteral nutrition as a primary therapy of Crohn's disease: the pediatric perspective. Nutr Clin Pract 2009, 24:91-97.
16. Isakson P., Hammarstedt A., Gustafson B., Smith U. Impaired preadipocyte differentiation in human abdominal obesity role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009, 58:1550-1557.
17. Schaffler A., Furst A., Buchler C., Paul G., Rogler G., Scholmerich J., et al. Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment. J Gastroenterol Hepatol 2006, 21:1412-1418.
18. Thomaz M.A., Acedo S.C., de Oliveira C.C., Pereira J.A., Priolli D.G., Saad M.J., et al. Methotrexate is effective in reactivated colitis and reduces inflammatory alterations in mesenteric adipose tissue during intestinal inflammation. Pharmacol Res 2009, 60:341-346.
19. Clemente T.R.L., dos Santos A.N., Sturaro J.N., Gotardo E.M.F., de Oliveira C.C., Acedo S.C., et al. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis. Scand J Gastroenterol 2012, 47:943-950.
20. Ohashi K., Parker J.L., Ouchi N., Higuchi A., Vita J.A., Gokce N., et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010, 285:6153-6160.
21. Valentini L., Wirth E.K., Schweizer U., Hengstermann S., Schaper L., Koernicke T., et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009, 25:172-181.
22. Ogunwobi O.O., Beales I.L.P. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006, 134:105-113.
23. Frederich R.C., Lollmann B., Hamann A., Napolitanorosen A., Kahn B.B., Lowell B.B., et al. Expression of OB messenger-RNA and its encoded protein in rodents - impact of nutrition and obesity. J Clin Invest 1995, 96:1658-1663.
24. Batra A., Okur B., Glauben R., Erben U., Ihbe J., Stroh T., et al. Leptin: a critical regulator of CD4(+) T-cell polarization in vitro and in vivo. Endocrinology 2010, 151:56-62.
25. Paul G., Schaffler A., Neumeier M., Furst A., Bataillle F., Buechler C., et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 2006, 12:471-477.
26. Patel L., Buckels A.C., Kinghorn I.J., Murdock P.R., Holbrook J.D., Plumpton C., et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003, 300:472-476.
27. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003, 309:286-290.
28. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174:5789-5795.
29. Peyrin-Biroulet L., Gonzalez F., Dubuquoy L., Rousseaux C., Dubuquoy C., Decourcelle C., et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012, 61:78-85.
30. Lucendo A.J., De Rezende L.C. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol 2009, 15:2081-2088.